We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
-8.53%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$1.79B
AUM Growth
-$211M
Cap. Flow
+$11.5M
Cap. Flow %
0.64%
Top 10 Hldgs %
29.44%
Holding
145
New
10
Increased
40
Reduced
13
Closed
6

Top Buys

Rank Stock Value
1
COLL icon
Collegium Pharmaceutical
COLL
+$14.5M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$9.75M
3
EPIX
ESSA Pharma
EPIX
+$8.87M
4
XLRN
Acceleron Pharma
XLRN
+$8.72M
5
PEGI
Pattern Energy Group Inc. Class A
PEGI
+$7.95M

Top Sells

Rank Stock Value
1
SCTY
SolarCity Corporation
SCTY
+$31.4M
2
EXR icon
Extra Space Storage
EXR
+$25.2M
3
EOG icon
EOG Resources
EOG
+$10.3M
4
CLDX icon
Celldex Therapeutics
CLDX
+$6.59M
5
CYBR
CyberArk
CYBR
+$4.96M

Sector Composition

Rank Sector Weight
1 Healthcare 30.49%
2 Technology 25.59%
3 Consumer Discretionary 14.14%
4 Industrials 7.47%
5 Utilities 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSIQ icon
51
Canadian Solar
CSIQ
$831M
$11.6M 0.65%
600,000
– –
ORA icon
52
Ormat Technologies
ORA
$5.61B
$11.6M 0.65%
280,359
+130,359
+87% +$4.84M
NVAX icon
53
Novavax
NVAX
$1.52B
$11.2M 0.63%
108,985
– –
XLRN
54
DELISTED
Acceleron Pharma
XLRN
$11.2M 0.62%
423,500
+300,000
+243% +$8.72M
AYR
55
DELISTED
Aircastle Ltd
AYR
$9.53M 0.53%
428,600
– –
ACAD icon
56
Acadia Pharmaceuticals
ACAD
$4.61B
$9.36M 0.52%
334,700
– –
SUPN icon
57
Supernus Pharmaceuticals
SUPN
$2.4B
$8.77M 0.49%
575,000
+77,000
+15% +$1M
LGND icon
58
Ligand Pharmaceuticals
LGND
$5.52B
$8.57M 0.48%
128,240
– –
DBVT
59
DBV Technologies
DBVT
$739M
$8.12M 0.45%
24,960
– –
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$8.02M 0.45%
393,000
-82,800
-17% -$2.63M
TSRO
61
DELISTED
TESARO, Inc.
TSRO
$7.92M 0.44%
180,000
– –
EPIX
62
DELISTED
ESSA Pharma
EPIX
$7.83M 0.44%
+135,971
New +$8.87M
HASI icon
63
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
$7.01M 0.39%
365,000
+277,000
+315% +$4.96M
FSLR icon
64
First Solar
FSLR
$21.7B
$6.85M 0.38%
+100,000
New +$6.7M
KITE
65
DELISTED
Kite Pharma, Inc.
KITE
$6.82M 0.38%
148,600
– –
SRPT icon
66
Sarepta Therapeutics
SRPT
$2.19B
$6.49M 0.36%
332,300
– –
BMRN icon
67
BioMarin Pharmaceuticals
BMRN
$12.5B
$6.19M 0.35%
75,000
– –
CERN
68
DELISTED
Cerner Corp
CERN
$5.73M 0.32%
108,200
– –
CSLT
69
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$5.69M 0.32%
1,708,600
– –
ALNY icon
70
Alnylam Pharmaceuticals
ALNY
$31.9B
$5.65M 0.32%
90,000
– –
RARE icon
71
Ultragenyx Pharmaceutical
RARE
$1.29B
$5.53M 0.31%
87,400
– –
SAGE
72
DELISTED
Sage Therapeutics
SAGE
$5.45M 0.3%
170,000
+44,100
+35% +$1.55M
GWPH
73
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.3M 0.3%
73,500
– –
NBIX icon
74
Neurocrine Biosciences
NBIX
$15.2B
$4.94M 0.28%
125,000
– –
PRTA icon
75
Prothena Corp
PRTA
$428M
$4.94M 0.28%
120,000
+15,200
+15% +$595K
1 2
3
4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q1 2016 Portfolio in Review

As of Q1 2016, Eventide Asset Management held 145 positions worth $1.79B, down 11% from $2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eventide Asset Management's Q1 2016 filing shows 10 new, 40 increased, 13 reduced and 6 closed positions. Its largest new stake was ESSA Pharma: 135,971 shares worth $7.83M. The largest sale was SolarCity Corporation, an estimated $31.4M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q1 2016 buy was ESSA Pharma: 135,971 shares worth $7.83M.
  • Eventide Asset Management added most to Collegium Pharmaceutical in Q1 2016, an estimated $14.5M increase.
  • Eventide Asset Management's biggest Q1 2016 reduction was Extra Space Storage, cutting an estimated $25.2M.
  • Eventide Asset Management fully exited SolarCity Corporation in Q1 2016, selling an estimated $31.4M.
  • Eventide Asset Management's ten largest holdings make up 29% of its $1.79B portfolio in Q1 2016.
  • Eventide Asset Management opened 10 new positions and closed 6 in Q1 2016.
  • Eventide Asset Management's portfolio value fell 11% quarter-over-quarter to $1.79B.

Based on Eventide Asset Management's 13F filing for Q1 2016, filed 16 May 2016.